This inventor holds 1 USPTO granted patent. Top assignees: Japan Science and Technology Corporation, Oriental Yeast Co., Ltd., Osaka Bioscience Institute. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2007
Title: Hiroaki Kitayama: Innovator in Genetic Engineering
Introduction
Hiroaki Kitayama is a prominent inventor based in Kyoto, Japan. He is known for his significant contributions to the field of genetic engineering, particularly in the development of transgenic animals for medical research. His innovative work has the potential to advance the understanding of various diseases and the testing of new therapies.
Latest Patents
Hiroaki Kitayama holds a patent titled "Animal with the mass expression of human gene and test method by using the animal." This patent describes a human gene over-expressing animal, which is a non-human animal that carries a human hematopoietic prostaglandin D synthase gene in its somatic cell chromosome. The animal expresses a large amount of human prostaglandin D synthase. The invention also provides a method for using this transgenic animal to test the in vivo activity of candidates for anti-allergy medicines, sleep-controlling substances, and anti-obesity treatments. He has 1 patent to his name.
Career Highlights
Throughout his career, Hiroaki Kitayama has worked with notable organizations such as the Japan Science and Technology Corporation and the Osaka Bioscience Institute. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Hiroaki Kitayama has collaborated with esteemed colleagues, including Yoshihiro Urade and Yasushi Fujitani. These partnerships have fostered a collaborative environment that has led to significant advancements in genetic research.
Conclusion
Hiroaki Kitayama's innovative work in genetic engineering exemplifies the potential of transgenic animals in medical research. His contributions are paving the way for new treatments and a deeper understanding of human health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile